Fan Y, Meng Y, Hu X, Liu J, Qin X
Cancer Cell Int. 2024; 24(1):268.
PMID: 39068486
PMC: 11282867.
DOI: 10.1186/s12935-024-03425-y.
Rojas A, Lindner C, Schneider I, Gonzalez I, Morales M
World J Gastroenterol. 2023; 29(6):997-1010.
PMID: 36844144
PMC: 9950863.
DOI: 10.3748/wjg.v29.i6.997.
Yu G, Li S, Wei R, Jiang Z
J Diabetes Res. 2022; 2022:1747326.
PMID: 35296101
PMC: 8920658.
DOI: 10.1155/2022/1747326.
Azizian-Farsani F, Abedpoor N, Sheikhha M, Gure A, Nasr-Esfahani M, Ghaedi K
Front Oncol. 2020; 10:552283.
PMID: 33117687
PMC: 7551201.
DOI: 10.3389/fonc.2020.552283.
Wu C, Du X, Tang L, Wu J, Zhao W, Guo X
Front Immunol. 2020; 11:1767.
PMID: 32973746
PMC: 7472961.
DOI: 10.3389/fimmu.2020.01767.
Targeting AXL and RAGE to prevent geminin overexpression-induced triple-negative breast cancer metastasis.
Ryan D, Koziol J, ElShamy W
Sci Rep. 2019; 9(1):19150.
PMID: 31844158
PMC: 6915698.
DOI: 10.1038/s41598-019-55702-w.
Up-Regulation of MiR-1915 Inhibits Proliferation, Invasion, and Migration of -Infected Gastric Cancer Cells via Targeting RAGE.
Xu X, Zhang W, Li C, Gao H, Pei Q, Cao B
Yonsei Med J. 2018; 60(1):38-47.
PMID: 30554489
PMC: 6298885.
DOI: 10.3349/ymj.2019.60.1.38.
Mast Cell-Dependent CD8 T-cell Recruitment Mediates Immune Surveillance of Intestinal Tumors in Apc Mice.
Bodduluri S, Mathis S, Maturu P, Krishnan E, Satpathy S, Chilton P
Cancer Immunol Res. 2018; 6(3):332-347.
PMID: 29382671
PMC: 9580996.
DOI: 10.1158/2326-6066.CIR-17-0424.
Hypoxia driven glycation: Mechanisms and therapeutic opportunities.
Imran Khan M, Rath S, Adhami V, Mukhtar H
Semin Cancer Biol. 2017; 49:75-82.
PMID: 28546110
PMC: 5699980.
DOI: 10.1016/j.semcancer.2017.05.008.
The Role of HMGB1 in the Pathogenesis of Type 2 Diabetes.
Wang Y, Zhong J, Zhang X, Liu Z, Yang Y, Gong Q
J Diabetes Res. 2017; 2016:2543268.
PMID: 28101517
PMC: 5215175.
DOI: 10.1155/2016/2543268.
Aggressiveness Niche: Can It Be the Foster Ground for Cancer Metastasis Precursors?.
ElShamy W, Sinha A, Said N
Stem Cells Int. 2016; 2016:4829106.
PMID: 27493669
PMC: 4963571.
DOI: 10.1155/2016/4829106.
Secreted HMGB1 from Wnt activated intestinal cells is required to maintain a crypt progenitor phenotype.
Reed K, Song F, Young M, Hassan N, Antoine D, Gemici N
Oncotarget. 2016; 7(32):51665-51673.
PMID: 27323825
PMC: 5239505.
DOI: 10.18632/oncotarget.10076.
A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women.
Chen L, Duan Z, Tinker L, Sangi-Haghpeykar H, Strickler H, Ho G
Cancer Epidemiol. 2016; 42:115-23.
PMID: 27100837
PMC: 4899266.
DOI: 10.1016/j.canep.2016.04.004.
Epithelial calcineurin controls microbiota-dependent intestinal tumor development.
Peuker K, Muff S, Wang J, Kunzel S, Bosse E, Zeissig Y
Nat Med. 2016; 22(5):506-15.
PMID: 27043494
PMC: 5570457.
DOI: 10.1038/nm.4072.
Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosis.
Sakellariou S, Fragkou P, Levidou G, Gargalionis A, Piperi C, Dalagiorgou G
BMC Cancer. 2016; 16:174.
PMID: 26931562
PMC: 4774155.
DOI: 10.1186/s12885-016-2213-5.
The Receptor for Advanced Glycation Endproducts Does Not Contribute to Pathology in a Mouse Mesenteric Ischemia/Reperfusion-Induced Injury Model.
Wu M, Gilmour T, Mantovani S, Woodruff T
Front Immunol. 2015; 6:614.
PMID: 26697010
PMC: 4670855.
DOI: 10.3389/fimmu.2015.00614.
Role of high-mobility group box 1 protein in inflammatory bowel disease.
Hu Z, Wang X, Gong L, Wu G, Peng X, Tang X
Inflamm Res. 2015; 64(8):557-63.
PMID: 26077468
DOI: 10.1007/s00011-015-0841-x.
Overexpression of the Receptor for Advanced Glycation Endproducts (RAGE) is associated with poor prognosis in gastric cancer.
Wang D, Li T, Ye G, Shen Z, Hu Y, Mou T
PLoS One. 2015; 10(4):e0122697.
PMID: 25860956
PMC: 4393278.
DOI: 10.1371/journal.pone.0122697.
Nuclear DAMP complex-mediated RAGE-dependent macrophage cell death.
Chen R, Fu S, Fan X, Lotze M, Zeh 3rd H, Tang D
Biochem Biophys Res Commun. 2015; 458(3):650-655.
PMID: 25684181
PMC: 4355398.
DOI: 10.1016/j.bbrc.2015.01.159.
RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment.
Nasser M, Wani N, Ahirwar D, Powell C, Ravi J, Elbaz M
Cancer Res. 2015; 75(6):974-85.
PMID: 25572331
PMC: 4359968.
DOI: 10.1158/0008-5472.CAN-14-2161.